The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Parikh, Samir Haresh
    W Planner born in January 1973
    Individual (7 offsprings)
    Officer
    2012-11-12 ~ now
    OF - Director → CIF 0
    Mr Samir Haresh Parikh
    Born in January 1973
    Individual (7 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Has significant influence or control over the trustees of a trustCIF 0
  • 2
    Pinto Emms, Juliana Cristina
    Operations Director born in April 1979
    Individual (1 offspring)
    Officer
    2022-12-21 ~ now
    OF - Director → CIF 0
  • 3
    506, Kingsbury Road, London, England
    Active Corporate (1 parent, 3 offsprings)
    Equity (Company account)
    571,182 GBP2023-10-31
    Person with significant control
    2017-06-02 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 1
  • Patel, Nitinkumar Ramanlal
    Finance Director born in February 1967
    Individual (4 offsprings)
    Officer
    2016-07-15 ~ 2017-06-02
    OF - Director → CIF 0
parent relation
Company in focus

NEXCAPE PHARMACEUTICALS LTD

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Par Value of Share
Class 1 ordinary share
02023-04-01 ~ 2024-03-31
Intangible Assets
2,700 GBP2024-03-31
5,700 GBP2023-03-31
Property, Plant & Equipment
416,629 GBP2024-03-31
415,525 GBP2023-03-31
Fixed Assets
419,329 GBP2024-03-31
421,225 GBP2023-03-31
Total Inventories
247,397 GBP2024-03-31
352,785 GBP2023-03-31
Debtors
1,818,292 GBP2024-03-31
1,496,686 GBP2023-03-31
Cash at bank and in hand
5,482 GBP2024-03-31
368,332 GBP2023-03-31
Current Assets
2,071,171 GBP2024-03-31
2,217,803 GBP2023-03-31
Creditors
Current
-2,171,805 GBP2024-03-31
-2,117,064 GBP2023-03-31
Net Current Assets/Liabilities
-100,634 GBP2024-03-31
100,739 GBP2023-03-31
Total Assets Less Current Liabilities
318,695 GBP2024-03-31
521,964 GBP2023-03-31
Creditors
Non-current
-272,175 GBP2024-03-31
-248,953 GBP2023-03-31
Net Assets/Liabilities
45,925 GBP2024-03-31
272,626 GBP2023-03-31
Equity
Called up share capital
10,000 GBP2024-03-31
10,000 GBP2023-03-31
Retained earnings (accumulated losses)
35,925 GBP2024-03-31
262,626 GBP2023-03-31
Equity
45,925 GBP2024-03-31
272,626 GBP2023-03-31
Average Number of Employees
62023-04-01 ~ 2024-03-31
62022-04-01 ~ 2023-03-31
Intangible Assets - Gross Cost
65,489 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
62,789 GBP2024-03-31
59,789 GBP2023-03-31
Intangible Assets - Increase From Amortisation Charge for Year
3,000 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
483,931 GBP2024-03-31
481,481 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
67,302 GBP2024-03-31
65,956 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,346 GBP2023-04-01 ~ 2024-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000,000 shares2024-03-31
Profit/Loss
Retained earnings (accumulated losses)
-226,701 GBP2023-04-01 ~ 2024-03-31

Related profiles found in government register
  • NEXCAPE PHARMACEUTICALS LTD
    Info
    Registered number 08290141
    20-22 Wenlock Road, London N1 7GU
    Private Limited Company incorporated on 2012-11-12 (12 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-06-06
    CIF 0
  • NEXCAPE PHARMACEUTICALS LTD
    S
    Registered number 08290141
    20-22, Wenlock Road, London, England, N1 7GU
    Limited Company in Companies House, England & Wales
    CIF 1
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
Ceased 1
  • 15 Martinfield Business Centre, Welwyn Garden City, Hertfordshire, England
    Active Corporate (3 parents)
    Equity (Company account)
    -934,287 GBP2023-12-31
    Person with significant control
    2016-06-13 ~ 2017-09-01
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Ownership of voting rights - 75% or more OE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.